<![CDATA[<body bgcolor="#FFFFFF" text="#000000">
Asia is the largest continent in the world in terms of its size as well as its population, which accounts for 60% of that of the world. Owing to its extensive size, the continent can be further fragmented into smaller regions on the basis of its very diverse cultures, races and ethnicities.
South Asia which includes India, Pakistan, Sri Lanka, Nepal, Maldives, Bangladesh, etc.
South East Asia encompassing Singapore, Malaysia, Indonesia, Philippines, Vietnam, Cambodia, Thailand, etc.
Far East consisting of China, Hong Kong, Taiwan, South Korea, North Korea, Japan, etc.
Middle East & West Asia comprising Bahrain, Jordan, UAE, Yemen, Iraq, Israel, Oman, Saudi Arabia, etc.
Central Asia covering Afghanistan, Iran, Iraq, etc.
Asia is also home to some of the largest pharmaceutical markets in terms of value, viz. Japan as well as in units, viz. India & China. Glenmark has a significant presence in this continent with activities across 15 countries and its homeland India.
Some of the key markets in Asia are:
Click the links below for details of each country :
South Asia
Sri Lanka
Maldives
Nepal
South East Asia
Philippines
Malaysia
Cambodia
Vietnam
Myanmar
Laos
Singapore
Thailand
Far East
Hong Kong
Middle East
Yemen
Oman
Iraq
UAE
Presence since: 1987
Therapy segment[s] of strength: Cough management, Dermatologicals, Anti-diabetic and
Anti-infectives..
Glenmark is amongst the leading companies in the Sri Lankan market with a product basket that includes popular brands like Ascoril and the Candid range. In this fiercely competitive market, Glenmark has a strong representation through its team of medical professionals and managers.
Presence since: 1990
Therapy segment[s] of strength: Dermatologicals, Cough management and Anti-infectives.
Presence since:
Therapy segment[s] of strength:
Presence since: 2003
Therapy segment[s] of strength: Dermatologicals.
The Philippines are amongst the leading markets in South East Asia with a size of USD 1.5 billion. Glenmark markets its products in the Philippines through its wholly owned subsidiary, Glenmark Philippines Incorporated and distributes them through Metro Drug, one of the country's largest distributors. A few of Glenmark's products are also sold through one of Philippines' most reputed pharmaceutical chains, Mercury Drug Stores. Glenmark is currently present in the dermatology specialty.
Presence since: 1981
Therapy segment[s] of strength: Dermatologicals.
Glenmark markets its products through its Representative Office in Malaysia, which is supported by a well-established filed force covering the entire country.
Presence since: 2002
Therapy segment[s] of strength: Cough management, Anti-infectives and Anti-diabetics.
Glenmark's products have been well received by the Cambodian medical fraternity as reflected in the company's rapid growth. This growth was augmented with Cambodia evolving as a disciplined prescription market following the war.
Presence since: 2002
Therapy segment[s] of strength: Gynaecologicals, Anti-infectives and Anti-diabetics.
For a market which is highly price sensitive and dominated by Indian companies, Glenmark has an unwavering presence in Vietnam with products across different therapy segments.
Presence since: 2002
Therapy segment[s] of strength: Anti-infectives, Dermatologicals and Anti-diabetics.
Myanmar is characterised by severe competition amidst volatility in pricing. The latter being the reason for Glenmark's late entry into this country which has a large Indian presence. Today, Glenmark has is represented across different therapy segments.
Presence since: 2005
Therapy segment[s] of strength: Gynaecologicals and Dermatologicals.
Laos is a market dominated by local companies with low priced and older generation of drugs. Glenmark has applied for 16 new generation product registrations.
Presence since: 1981
Therapy segment[s] of strength: Dermatologicals and Cardiovascular.
Singapore is a small but regulated market in which Glenmark markets its range of dermatology products.
Presence since: 1986
Therapy segment[s] of strength: Dermatologicals.
Thailand is a highly regulated market with a well developed local pharmaceutical industry and was identified by Glenmark as a major growth area.
Presence since: 2002
Therapy segment[s] of strength: Gynaecologicals, Dermatologicals and Anti-diabetics.
Presence since: 1987
Therapy segment[s] of strength: Cough management, Dermatologicals and Anti-diabetics.
Glenmark's marketing team in Yemen, which is supported by a strong distribution network, ensures that its products are promoted in all major towns and cities across the country.
Presence since: 1981
Therapy segment[s] of strength: Dermatologicals and Gynaecologicals.
Glenmark commenced its operations in Oman more than two decades ago and has emerged as a leader in dermatology with its topical antifungal preparation 'Candid'.
Presence since: 2004
Therapy segment[s] of strength: Gynaecologicals.
Presence since: 1983
Therapy segment[s] of strength: Nutritional Supplements.
Currently, Glenmark has one product registered in the UAE. Five more products have been lined up for registration, to help Glenmark establish itself as a major player.
</body>]]>